Sanofi and Regeneron's high-flying Dupixent tops May pharma TV spending, trading...

cafead

Administrator
Staff member
  • cafead   Jun 17, 2021 at 12:22: PM
via Sanofi and Regeneron’s asthma and eczema drug climbed back to No. 1 in May, while AbbVie’s blockbuster anti-inflammatory dropped again to second, according to data from real-time TV ad tracker iSpot.tv.

article source